Previous study showed that soy isoflavone supplement alleviates disease severity in autoimmune-prone mice. As the ethyl acetate extract of alfalfa sprout (AS) has selective oestrogenic and anti-inflammatory activity, this study evaluated the effects of alfalfa sprout ethyl acetate extract (ASEA) on disease severity of systemic lupus erythematosus, using autoimmune-prone female MRL-lpr/lpr mice. In Experiment 1, five groups of 12-week-old female mice were per oral treated with vehicle (control), lyophilized AS (550 mg wt/kg BW), ASEA (ASEA, 25 mg/kg BW), coumestrol (CUM, 0.075 mg/kg BW) and tamoxifen (TAM, 0.375 mg/kg BW) as the positive control. The onset of proteinuria was delayed, and the life span was significantly longer in the ASEA and TAM groups but neither in the AS nor in the CUM groups, compared to the control. To examine the changes in the immunological parameters related to disease process, three more groups of MRL-lpr/lpr female mice (control, ASEA and TAM) were fed in a similar manner for 6 weeks in the Experiment 2. Flow cytometric analysis of splenocytes showed a significantly lower percentage of activated T cells in the ASEA and TAM groups. The ex-vivo interferon-γ and interleukin (IL)-4 production from splenocytes and tumour necrosis factor-α and IL-1β production from peritoneal exudate cells were also significantly lower in the ASEA group compared with the control. The ASEA group also had less severe glomerulonephritis. Thus, ASEA attenuated cytokine and inflammatory responses of self-reactive lymphocytes, decreased the disease severity, increased survival and life span of the autoimmune-prone MRL-lpr/lpr mice, suggesting a potential of ASEA in the treatment of autoimmune diseases.
1 Edwards CJ James JA . Making lupus: a complex blend of genes and environmental factors is required to cross the disease threshold. Lupus2005; 15: 713–714.
2.
2 Leiba A Amital H Gershwin ME Shoenfeld Y . Diet and lupus. Lupus2001; 10: 246–248.
3.
3 Lin BF Jeng SJ Chiang BL Huang CC . Dietary fat affects lipids and anti-cardiolipin antibody levels in autoimmune-prone NZB/W F1 mice. Br J Nutr1997; 77: 657–669.
4.
4 Hsieh CC Lin BF . The effects of vitamin E supplementation on autoimmune-prone New Zealand black × New Zealand white F1 mice fed an oxidised oil diet. Br J Nutr2005; 93: 655–662.
5.
5 Lai NS Lin RH Lai RS Kun UC Leu SC . Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice with an ancient Chinese herb, Ganoderma tsugae. Lupus2001; 10: 461–465.
6.
6 Auborn KJ Qi M Yan XJ . Life span is prolonged in autoimmune-prone (NZB/NZW) F1 mice fed a diet supplemented with indole-3-carbinol. J Nutr2003; 133: 3610–3613.
7.
7 Sawai C Anderson K Walser-Kuntz D . Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB × NZW F1 mice. Environ Health Perspect2003; 111: 1883–1887.
8.
8 Lahita RG . The importance of estrogen in systemic lupus erythematosus. Clin Immunol Immunopathol1992; 63: 17–18.
9.
9 Cooper GS Dooley MA Treadwell EL St. Clair EW Parks CG . Hormonal, environmental, and infectious, risk factors for developing systemic lupus erythematosus. Arthritis Rheum1998; 41: 1714–1724.
10.
10 Carlsten H Tarkowski A Holmdahl R Nilsson LA . Oestrogen is a potent disease accelerator in SLE-prone MRL-lpr/lpr mice. Clin Exp Immunol1990; 80: 467–473.
11.
11 Dhaher YY Greenstein B de Fougerolles Nunn F Khamashta M Hughes GR . Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus. Int J Immunopharmacol2000; 22: 247–254.
12.
12 Kuiper GG Lemmen JG Carlsson B . Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology1998; 139: 4252–4263.
13.
13 Morito K Aomori T Hirose T . Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull2002; 25: 48–52.
14.
14 Birt DF Hendrich S Wang W . Dietary agents in cancer prevention: 9 flavonoids and isoflavonoids. Pharmacol Ther2001; 90: 157–177.
15.
15 Verdrengh M Jonsson IM Holmdahl R Tarkowski A . Genistein as an anti-inflammatory agent. Inflamm Res2003; 52: 341–346.
16.
16 Hong YH Wang TC Huang CJ Cheng WY Lin BF . Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice. Lupus (in press).
17.
17 Middleton MR Lorigan P Owen J . A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma. Br J Cancer2000; 82: 1158–1162.
18.
18 Cheng WY Kuo YH Huang CJ . Isolation and identification of novel estrogenic compounds in yam tuber (Dioscorea alata Cv. Tainung No. 2). J Agric Food Chem2007; 55: 7350–7358.
19.
19 Malinow MR McLaughlin P Stafford C Livingston AL Kohler GO . Alfalfa saponins and alfalfa seeds. Dietary effects in cholesterol-fed rabbits. Atherosclerosis1980; 37: 433–438.
20.
20 Swain SM Armentano LE . Quantitative evaluation of fiber from nonforage sources used to replace alfalfa silage. J Dairy Sci1994; 77: 2318–2331.
21.
21 Foster S Duke JA . A field guide to medicinal plants and herbs: eastern and central North America. In: RT Peterson , (ed), Houghton Mifflin Co, Boston, Massachusetts; 1990. p. 211.
22.
22 Malinow MR Bardana EJ Pirofsky B Craig S McLaughlin P . Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science1982; 216: 415–417.
23.
23 Montanaro A Bardana EJ . Dietary amino acid-induced systemic lupus erythematosus. Rheum Dis Clin North Am1991; 17: 323–332.
24.
24 Roberts JL Hayashi JA . Exacerbation of SLE associated with alfalfa ingestion. N Engl J Med1983; 308: 1361.
25.
25 Alcocer-Varela J Iglesias A Llorente L Alarcon-Segovia D . Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum1985; 28: 52–57.
26.
26 Akaogi J Barker T Kuroda Y . Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun Rev2006; 5: 429–435.
27.
27 Wu WM Suen JL Lin BF Chiang BL . Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice. Immunology2000; 100: 110–118.
28.
28 National Research Council. Guide for the care and use of laboratory animals. Publication no. 85–23 (rev.), National Institutes of Health, Bethesda, MD, (1985).
29.
29 Li J McMurray RW . Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin Immunol2007; 123: 219–226.
30.
30 Prete PE . Effects of L-canavanine on immune functioning in normal and autoimmune mice: disordered B-cell function by a dietary amino acid in the immunoregulation of autoimmune disease. Can J Physiol Pharmacol1985; 63: 843–854.
31.
31 Bovee TF Schoonen WG Hamers AR Bento MJ Peijnenburg AA . Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities. Anal Bioanal Chem2008; 390: 1111–1119.
32.
32 Schoenroth LJ Hart DA Pollard KM Fritzler MJ . The effect of the phytoestrogen coumestrol on the NZB/W F1 murine model of systemic lupus. J Autoimmun2004; 23: 323–332.
33.
33 Stochmal A Piacente S Pizza C De Riccardis F Leitz R Oleszek W . Alfalfa (Medicago sativa L.) flavonoids. 1. Apigenin and luteolin glycosides from aerial parts. J Agric Food Chem2001; 49: 753–758.
34.
34 Saloniemi H Wähälä K Nykänen-Kurki P Kallela K Saastamoinen I . Phytoestrogen content and estrogenic effect of legume fodder. Proc Soc Exp Biol Med1995; 208: 13–17.
35.
35 Story JA LePage SL Petro MS . Interactions of alfalfa plant and sprout saponins with cholesterol in vitro and in cholesterol-fed rats. Am J Clin Nutr1984; 39: 917–929.
36.
36 Rowlands JC Berhow MA Badger TM . Estrogenic and antiproliferative properties of soy sapogenols in human breast cancer cells in vitro. Food and Chem Toxicol2002; 40: 1767–1774.
37.
37 Cho J Park W Lee S Ahn W Lee Y . Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-alpha and -beta, independent of ligand binding. J Clin Endocrinol Metab2004; 89: 3510–3515.
38.
38 Nicholas C Batra S Vargo MA . Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol2007; 179: 7121–7127.
39.
39 Kang JH Sung MK Kawada T . Soybean saponins suppress the release of pro-inflammatory mediators by LPS-stimulated peritoneal macrophages. Cancer Lett2005; 230: 219–227.
40.
40 Su CC Shau WY Wang CR Chuang CY Chen CY . CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity. Lupus1997; 6: 449–454.
41.
41 Chae BS Shin TY . Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice. Arch Pharm Res2007; 30: 191–198.
42.
42 Nagahama M Nomura S Ozaki Y Yoshimura C Kagawa H Fukuhara S . Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity2001; 33: 85–94.
43.
43 Voronov E Dayan M Zinger H . IL-1 beta-deficient mice are resistant to induction of experimental SLE. Eur Cytokine Netw2006; 17: 109–116.
44.
44 Moosig F Zeuner R Renk C Schröder JO . IL-1RA in refractory systemic lupus erythematosus. Lupus2004; 13: 605–606.
45.
45 Manolios N Schrieber L Nelson M Geczy CL . Enhanced interferon-gamma (IFN-γ) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice. Clin Exp Immunol1989; 76: 301–306.
46.
46 Prud’homme GJ Jono DH Theofilopoulos AN . Quantitative polymerase chain reaction analysis reveals marked overexpression of IL-1β, IL-10 and IFN-γ mRNA in the lymph nodes of lupus-prone mice. Mol Immunol1995; 32: 495–503.
47.
47 Cuadrado MJ Marubayashi M Ortega C . Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients. Lupus1993; 2: 257–260.
48.
48 Peng SL Mosheli J Craft J . Roles of IFN-γ and IL-4 in murine lupus. J Clin Invest1997; 99: 1936–1946.
49.
49 Wong CK Ho CY Li EK Lam CW . Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus2000; 9: 589–593.
50.
50 Nakajima A Hirose S Yagita H Okumura K . Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J Immunol1997; 158: 1466–1472.
51.
51 Klinman DM . IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma. J Immunol1990; 144: 2529–2534.
